Intervention not reported
Antigenaemia prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in antigenaemia prevalence (high certainty).
1 finding from 1 review
Intervention not reported
Antigen density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Adult worm prevalence detected by ultrasound ‐ not measured · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Mf density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Antigenaemia prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in antigenaemia prevalence (high certainty).
1 finding from 1 review
Intervention not reported
Antigen density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Adult worm prevalence detected by ultrasound · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adult worm prevalence detected by ultrasound (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adverse events (high certainty).
1 finding from 1 review
Intervention not reported
Microfilaraemia (mf) prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in microfilaraemia (mf) prevalence (high certainty).
1 finding from 1 review
Intervention not reported
Mf density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Virological success · antiretroviral‐naïve individuals
The intervention showed no clear difference in virological success (high certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: pyrexia · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: pyrexia (low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: raised transaminases · antiretroviral‐naïve individuals
The intervention leads to lower severe adverse events: raised transaminases (high certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: raised alkaline phosphatase · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: raised alkaline phosphatase (low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: raised amylase · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: raised amylase (low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: raised triglycerides · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: raised triglycerides (low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: neutropenia · antiretroviral‐naïve individuals
The intervention leads to lower severe adverse events: neutropenia (high certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: rash · antiretroviral‐naïve individuals
The intervention showed no clear difference in severe adverse events: rash (moderate certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events: serum glutamic oxaloacetic transaminase (SGOT) · antiretroviral‐naïve individuals
1 finding from 1 review